Phase two clinical trial of limited stage lymphoblastic lymphoma.
Phase 2
Recruiting
- Conditions
- imited stage lymphoblastic lymphoma
- Registration Number
- JPRN-UMIN000002213
- Lead Sponsor
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Not provided
Exclusion Criteria
1, Down's syndrome 2, previous malignancy of any type 3, Prior stem cell or organ transplantation 4, Congenital or acquired immunodeficiency
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method